This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2024 Mar 5;12(3):e008226corr1.

doi: 10.1136/jitc-2023-008226corr1.

Correction: Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma

No authors listed

PMID: 38448039
PMCID: PMC10916080
DOI: 10.1136/jitc-2023-008226corr1

Published Erratum

Correction: Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma

No authors listed. J Immunother Cancer. 2024.

. 2024 Mar 5;12(3):e008226corr1.

doi: 10.1136/jitc-2023-008226corr1.

PMID: 38448039
PMCID: PMC10916080
DOI: 10.1136/jitc-2023-008226corr1

No abstract available

PubMed Disclaimer

Erratum for

Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma.
Tian J, Luo J, Zeng X, Ke C, Wang Y, Liu Z, Li L, Zhang Y, Hu Z, Yang C. Tian J, et al. J Immunother Cancer. 2024 Feb 14;12(2):e008226. doi: 10.1136/jitc-2023-008226. J Immunother Cancer. 2024. PMID: 38355278 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources